-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Verastem, Raises Price Target to $14

Benzinga·10/16/2026 11:47:08
Diffusion vocale
Mizuho analyst Graig Suvannavejh maintains Verastem (NASDAQ:VSTM) with a Outperform and raises the price target from $13 to $14.